Joycelyn X. Lee
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Integrating efficacy and safety profile in advanced HCC: A network meta-analysis of first-line systemic therapies.
Journal: JNCI cancer spectrum
Published: February 09, 2026
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer.
Journal: ESMO open
Published: June 03, 2025
Innate lymphoid cell heterogeneity and etiology-specific reprogramming in hepatocellular carcinoma.
Journal: NPJ precision oncology
Published: May 02, 2025
Impact of Etiology on Efficacy Outcomes with Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Retrospective Analysis in Asia-Pacific.
Journal: Targeted oncology
Published: September 16, 2024
Clinical Outcomes of Neoadjuvant Therapy Versus Upfront Surgery in Resectable Pancreatic Cancer: Systematic Review and Meta-analysis of Latest Randomized Controlled Trials.
Journal: Annals of surgical oncology
Published: July 23, 2024
Impact of Antibiotics and Chronic Medications on Efficacy of Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma.
Journal: Asia-Pacific journal of clinical oncology
Published: March 03, 2024
Multimodal molecular landscape of response to Y90-resin microsphere radioembolization followed by nivolumab for advanced hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: July 16, 2023
CD38 marks the exhausted CD8+ tissue-resident memory T cells in hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: March 08, 2023
Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: January 25, 2023
Last Updated: 09/26/2026